News

Impax Laboratories has initiated a challenge of the patents listed by Galderma Laboratories, in connection with its ORACEA (doxycycline) delayed-release capsules, 40mg. Impax filed its Abbreviated New Drug

Amgen has announced detailed results from a phase 3 trial evaluating denosumab administered subcutaneously versus Zometa (zoledronic acid) administered as an intravenous infusion in the treatment of bone

Anavex Life Sciences has announced the completion of scale-up manufacturing of ANAVEX 2-73, its compound for the treatment of Alzheimer’s disease. Herve de Kergrohen, CEO of Anavex, said:

Galderma and Ipsen have announced that Azzalure (botulinum toxin type A manufactured by Ipsen), a local muscle relaxant specifically developed for aesthetic use, has received a marketing authorization

Glenmark Pharmaceuticals, a research-driven, global, integrated pharmaceutical, has said that it will raise INR12 billion. The company will raise the amount from overseas markets or by private placement

Varian has launched a suite of new products to enhance the flexibility and automated use of its 400-MR Nuclear Magnetic Resonance (NMR) system. The collection of new tools

Celsion has announced that the Data Safety Monitoring Board (DSMB) has reviewed the safety data from the first group of patients enrolled in its pivotal ThermoDox phase III

Valeant Pharmaceuticals has provided update on the regulatory applications to the FDA and the European Medicines Agency (EMEA) for the investigational drug retigabine, a neuronal potassium channel opener

MedImmune has revealed that the US Department of Health and Human Services (HHS) has placed an order for an additional 29 million doses of its live attenuated influenza